Apricus Biosciences (APRI) and NeoPharm (NEOL) Sign Licensing Agreement for Vitaros(R) in Israel for up to $4.35 Million, Plus Royalties
2/14/2011 9:59:45 AM
More...
|
Dr. Daniel Von Hoff Joins INSYS Therapeutics/NeoPharm (NEOL) as Chief Development Officer
1/7/2011 9:47:47 AM
More...
|
Dr. Daniel Von Hoff Joins INSYS Therapeutics/NeoPharm (NEOL) As Chief Development Officer
1/6/2011 11:39:41 AM
More...
|
NeoPharm (NEOL) Completes Merger with INSYS Therapeutics
11/10/2010 10:42:54 AM
More...
|
NeoPharm (NEOL) Announces Merger with INSYS Therapeutics
11/1/2010 10:05:18 AM
More...
|
NeoPharm (NEOL) Announces Second Quarter 2010 Financial Results
8/26/2010 8:27:40 AM
More...
|
NeoPharm (NEOL) Announces First Quarter 2010 Financial Results and Clinical Trial Update
6/11/2010 9:46:12 AM
More...
|
NeoPharm (NEOL) Announces FDA Grant of Orphan Drug Designation for IL13-PE38QQR for the Treatment of Idiopathic Pulmonary Fibrosis
5/17/2010 10:00:46 AM
More...
|
NeoPharm (NEOL) Starts Enrolling Pancreatic Cancer Patients in Phase II Trial of LE-DT
4/20/2010 9:56:39 AM
More...
|
NeoPharm (NEOL) Announces Fourth Quarter And Full Year 2009 Financial Results
3/18/2010 10:31:53 AM
More...
|
|